Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 1.03B | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | 1.03B | |
| Cost of Revenue | -- | -- | -- | 720.74M | |
| Gross Profit | -- | -- | -- | 308.45M | |
| SG&A Expenses | -- | -- | -- | 257.70M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -237.60K | |
| Total Operating Expenses | -- | -- | -- | 978.20M | |
| Operating Income | -- | -- | -- | 50.99M | |
| Income Before Tax | -- | -- | -- | 24.41M | |
| Income Tax Expenses | -- | -- | -- | 10.93M | |
| Earnings from Continuing Operations | -- | -- | -- | 13.48 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -- | 13.48M | |
| EBIT | -- | -- | -- | 50.99M | |
| EBITDA | -- | -- | -- | 109.77M | |
| EPS Basic | -- | -- | -- | 0.03 | |
| Normalized Basic EPS | -- | -- | -- | 0.04 | |
| EPS Diluted | -- | -- | -- | 0.03 | |
| Normalized Diluted EPS | -- | -- | -- | 0.04 | |
| Average Basic Shares Outstanding | -- | -- | -- | 1.63B | |
| Average Diluted Shares Outstanding | -- | -- | -- | 1.63B | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |